Smith & Nephew SNATS Inc - Asset Resilience Ratio
Smith & Nephew SNATS Inc (SNN) has an Asset Resilience Ratio of -0.69% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1985–2021)
This chart shows how Smith & Nephew SNATS Inc's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Smith & Nephew SNATS Inc to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Smith & Nephew SNATS Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Smith & Nephew SNATS Inc (SNN) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $-69.00 Million | -0.69% |
| Total Liquid Assets | $-69.00 Million | -0.69% |
Asset Resilience Insights
- Limited Liquidity: Smith & Nephew SNATS Inc maintains only -0.69% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Smith & Nephew SNATS Inc Industry Peers by Asset Resilience Ratio
Compare Smith & Nephew SNATS Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Vieworks Co. Ltd
KQ:100120 |
Medical Devices | 7.81% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Respiri Ltd
AU:RSH |
Medical Devices | 0.46% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Implanet SA
PA:ALIMP |
Medical Devices | 0.55% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Smith & Nephew SNATS Inc (1985–2021)
The table below shows the annual Asset Resilience Ratio data for Smith & Nephew SNATS Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | -1.67% | $-182.00 Million | $10.92 Billion | -0.46pp |
| 2020-12-31 | -1.21% | $-133.00 Million | $11.01 Billion | -0.07pp |
| 2019-12-31 | -1.14% | $-106.00 Million | $9.30 Billion | +0.00pp |
| 2018-12-31 | -1.14% | $-92.00 Million | $8.06 Billion | -0.35pp |
| 2017-12-31 | -0.79% | $-62.00 Million | $7.87 Billion | -0.80pp |
| 2015-12-31 | 0.01% | $1.00 Million | $7.17 Billion | -2.95pp |
| 2012-12-31 | 2.96% | $167.00 Million | $5.64 Billion | -0.03pp |
| 2011-12-31 | 2.99% | $142.00 Million | $4.75 Billion | +2.68pp |
| 2009-12-31 | 0.31% | $14.00 Million | $4.57 Billion | -4.16pp |
| 2005-12-31 | 4.47% | $133.00 Million | $2.98 Billion | -2.12pp |
| 2004-12-31 | 6.59% | $192.27 Million | $2.92 Billion | -8.84pp |
| 2003-12-31 | 15.43% | $342.86 Million | $2.22 Billion | -- |
| 2000-12-31 | 0.00% | $0.00 | $1.44 Billion | -- |
| 1999-12-31 | 0.00% | $0.00 | $1.59 Billion | -- |
| 1998-12-31 | 0.00% | $0.00 | $1.50 Billion | -- |
| 1997-12-31 | 0.00% | $0.00 | $1.43 Billion | -- |
| 1996-12-31 | 0.00% | $0.00 | $1.44 Billion | -- |
| 1995-12-31 | 0.10% | $1.24 Million | $1.27 Billion | -0.13pp |
| 1994-12-31 | 0.22% | $2.97 Million | $1.32 Billion | 0.00pp |
| 1993-12-31 | 0.23% | $2.96 Million | $1.31 Billion | -0.77pp |
| 1991-12-31 | 0.99% | $15.72 Million | $1.58 Billion | -6.44pp |
| 1990-12-31 | 7.43% | $114.00 Million | $1.53 Billion | -1.81pp |
| 1989-12-31 | 9.24% | $125.00 Million | $1.35 Billion | +3.48pp |
| 1988-12-31 | 5.76% | $73.34 Million | $1.27 Billion | -2.86pp |
| 1987-12-31 | 8.62% | $105.86 Million | $1.23 Billion | +2.47pp |
| 1986-12-31 | 6.16% | $54.70 Million | $888.50 Million | -2.22pp |
| 1985-12-31 | 8.37% | $53.88 Million | $643.40 Million | -- |
About Smith & Nephew SNATS Inc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more